Granted Patent
S1
US 1,081,702 · App. 29/652,731 · Granted Jul 1, 2025
Display screen with a graphical user interface
Inventors:
Frederik Malfait (Wolfenschiessen, CH); Maurice Williams (Canton, MI); Robert Ross (Lumberton, NJ)
Assignee:
Nurocor, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Claims (1)
The ornamental design for a display screen with a graphical user interface, as shown and described.
Assignments (2)
SECURITY INTEREST
Recorded Jul 30, 2021
From: JOHN P. NORTON, AS TRUSTEE OF THE NORTON FAMILY TRUST
To: NUROCOR, INC.
Reel/Frame 057041/0358 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Dec 17, 2020
From: MALFAIT, FREDERIK; WILLIAMS, MAURICE; ROSS, ROBERT
To: NUROCOR, INC.
Reel/Frame 054682/0978 →
References Cited (118)
US D344102S
· Polak
· 1994
[cited by examiner]
US D502184S
· Glezer
· 2005
[cited by examiner]
US 7030890B1
· Jouet
· 2006
[cited by examiner]
US D594911S
· Hall
· 2009
[cited by examiner]
US 7818689B2
· Wada
· 2010
[cited by examiner]
US 8286072B2
· Chamberlain
· 2012
[cited by examiner]
US D673577S
· Cojuangco
· 2013
[cited by examiner]
US D698361S
· Stiffler
· 2014
[cited by examiner]
US D715834S
· Siddons
· 2014
[cited by examiner]
US D723048S
· Helliker
· 2015
[cited by examiner]
US D732058S
· Landis
· 2015
[cited by examiner]
US D753174S
· Cojuangco
· 2016
[cited by examiner]
US D759072S
· Siddons
· 2016
[cited by examiner]
US D769315S
· Scotti
· 2016
[cited by examiner]
US D771107S
· Spector
· 2016
[cited by examiner]
US D772276S
· Yampolskiy
· 2016
[cited by examiner]
US D788790S
· Omata
· 2017
[cited by examiner]
US D792448S
· Take
· 2017
[cited by examiner]
US D799499S
· Selden
· 2017
[cited by examiner]
US D803248S
· Sunshine
· 2017
[cited by examiner]
US D819687S
· Yampolskiy
· 2018
[cited by examiner]
US D841030S
· Bradley-Pollack
· 2019
[cited by examiner]
US D841031S
· Orlando
· 2019
[cited by examiner]
US D841675S
· Hoffman
· 2019
[cited by examiner]
US D854558S
· Melillo
· 2019
[cited by examiner]
US D855634S
· Kim
· 2019
[cited by examiner]
US D870762S
· Mendoza Corominas
· 2019
[cited by examiner]
US D873846S
· Melillo
· 2020
[cited by examiner]
US D877747S
· Belliveau
· 2020
[cited by examiner]
US D880517S
· Imamura
· 2020
[cited by examiner]
US D881927S
· Tsukahara
· 2020
[cited by examiner]
US D882598S
· Belliveau
· 2020
[cited by examiner]
US D895642S
· Hoofnagle
· 2020
[cited by examiner]
US D900840S
· Dudey
· 2020
[cited by examiner]
US D916869S
· Evangeliou
· 2021
[cited by examiner]
US D922422S
· Molander
· 2021
[cited by examiner]
US D924906S
· Nie
· 2021
[cited by examiner]
US D924909S
· Nasu
· 2021
[cited by examiner]
US D928194S
· Baker
· 2021
[cited by examiner]
US D937862S
· Anderson
· 2021
[cited by examiner]
US D950580S
· Ahmed
· 2022
[cited by examiner]
US D963677S
· Bahatyrevich
· 2022
[cited by examiner]
US D978887S
· Caro
· 2023
[cited by examiner]
US D980863S
· Balsamo
· 2023
[cited by examiner]
US D985602S
· Walecka
· 2023
[cited by examiner]
US 20050055241A1
· Horstmann
· 2005
[cited by applicant]
US 20110153358A1
· Campo et al.
· 2011
[cited by applicant]
US 20140039921A1
· Broverman et al.
· 2014
[cited by applicant]
US 20170286456A1
· Wenzel et al.
· 2017
[cited by applicant]
US 20170323320A1
· Mendoza Corominas
· 2017
[cited by examiner]
US 20180261305A1
· Lindblad
· 2018
[cited by examiner]
US 20220005558A1
· Malfait et al.
· 2022
[cited by applicant]
US 20230274809A1
· Dimitrova
· 2023
[cited by applicant]
US 20230360779A1
· Gnanasambandam et al.
· 2023
[cited by applicant]
Kemegne, Gislaine Aurelie et al., Comparing checkerboard, isobologram and CCD methods for drug combination, Oct. 31, 2021, AcademicJournals.org, retrieved Oct. 24, 2023, https://academicjournals.org/journal/JMPR/article…
[cited by examiner]
Dandapandi, Hari G., Leveraging Mobile-Based Sensors for Clinical Research, Jun. 13, 2022, FrontiersIn.org, retrieved Feb. 28, 2025, https://www.frontiersin.org/journals/digital-health/articles/10.3389/fdgth.2022.893070…
[cited by examiner]
Kriebel, Andy, How to Create a Dot Strip Plot, Jun. 8, 2021, YouTube.com, retrieved Feb. 28, 2025, https://www.youtube.com/watch?v=fKSL-IMqILA (Year: 2021).
[cited by examiner]
“Clinical trials and their patients: The rising costs and how to stem the loss,” Pharmafile, accessed from http:/www.pharmafile.com/print/511225, Mar. 11, 2016, 6 pp.
[cited by applicant]
“ICH E9 (R1) addendum on estimands and sensitivity analysis in clinical trials to the guideline on statistical principles for clinical trials,” European Medicines Agency, Committee for Medicinal Products for Human Use, …
[cited by applicant]
“Nurocor Clinical Platform—Technical Perspective,” Nurocor, Inc., accessed on Apr. 29, 2020, 11 pp.
[cited by applicant]
“Optimize Clinical Development,” Nurocor and Intilaris brochure, accessed on Sep. 9, 2020, 2 pp.
[cited by applicant]
Nelson et al., “CDISC 2019 US Interchange,” [Presentation], CDISC, San Diego, CA, Oct. 14-18, 2019, 19 pp.
[cited by applicant]
Kountouris et al., “Efficient scheduling of conditional behaviors for high-level synthesis,” ACM Transactions on Design Automation of Electronic Systems, vol. 7, No. 3, Jul. 1, 2002, pp. 380-412.
[cited by applicant]
Lin et al., “A Standard-Driven Approach for Electric Submission to Pharmaceutical Regulatory Authorities”, Journal of Biomedical Informatics, vol. 79, Jan. 31, 2018, pp. 60-70.
[cited by applicant]
“Executive Summary—Digital Data Flow Solution Framework and Conceptual Design, Version 1.0,” TransCelebrate Biopharma, Inc., Nov. 7, 2019, 4 pp.
[cited by applicant]
“Digital Data Flow Solution Framework and Conceptual Design, Version 1.0,” TransCelebrate DDF Project Team, TransCelebrate Biopharma, Inc., Nov. 1, 2019, 46 pp.
[cited by applicant]
“Reusable Asset Specification, Version 2.2,” Object Management Group (OMG), accessed from https://www.omg.org/spec/RAS/2.2/PDF, Nov. 2005, 121 pp.
[cited by applicant]
Nelson et al., PowerPoint presented at 2019 Clinical Data Interchange Standards Consortium (CDISC) US Interchange, San Diego, California, Oct. 14-18, 2018, 19 pp.
[cited by applicant]
“Cost of Developing a New Drug,” Tufts Center for the Study of Drug Development (CSDD), Tufts University, School of Medicine, Nov. 18, 2014, 30 pp.
[cited by applicant]
“Drug Approval Process—Infographic,” U.S. Food and Drug Administration (FDA), accessed from http://www.fda.gov/downloads/Drugs/ResourcesForYou/Consumers/UCM284393.pdf, accessed on Jan. 20, 2015, 2 pp.
[cited by applicant]
Burrows, “Report: The 8 biggest challenges facing clinical trail professionals,” Informa Connect, Clinical & Medical Affairs, accessed from https://informaconnect.com/report-biggest-challenges-clinical-trials-pt-1/, Nov…
[cited by applicant]
Nelson et al., “3D Standardized in Clinical Development to achieve End-to-End Automation,” Intilaris, Nurocor, 2019 Clinical Data Interchange Standards Consortium (CDISC), Oct. 14-18, 2019, 5 pp.
[cited by applicant]
“How to avoid costly clinical research delays,” MESM Blog, accessed from https://www.mesm.com/blog/tips-to-help-you-avoid-costly-clinical-research-delays/, dated Jan. 16, 2020, accessed on Mar. 4, 2021, 4 pp.
[cited by applicant]
Hargreaves, “Clinical trails and their patients: The rising costs and how to stem the loss,” Pharmafile, accessed from http://www.pharmafile.com/news/511225/clinical-trials-and-their-patients-rising-costs-and-how-stem-l…
[cited by applicant]
Woodcock et al., “Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both,” Massachusetts Medical Society, The New England Journal of Medicine, Jul. 6, 2017, 9 pp.
[cited by applicant]
“Nurocor products allow customers to automate clinical development processes from protocol to submission,” NUROCOR Brochure, accessed from www.nurocor.com, accessed on Sep. 10, 2019, 4 pp.
[cited by applicant]
“Streamline Your Clinical Operations Through Smarter Standardization,” Nurocor, PowerPoint presented at 2019 Clinical Data Interchange Standards Consortium (CDISC), US Interchange, San Diego, California, Oct. 18, 2019, …
[cited by applicant]
“Facts about Clinical Trials,” Arena International, accessed from https://web.archive.org/web/20180914235739/http://www.arena-international.com/clinicaltrials/facts-about-clinical-trials/1063.article, dated Sep. 14, 201…
[cited by applicant]
“Study Data Tabulation Model Implementation Guide: Human Clinical Trials,” Prepared by the CDISC Submission Standards Team, cdisc, Version 3.3 (Final), Clinical Data Interchange Standards Consortium, Inc., Nov. 20, 2018…
[cited by applicant]
“Biotech Out-Licensed Optimized Compound Value—Product Oriented Licensing Strategy,” Intilaris LifeSciences, accessed on Sep. 9, 2020, 6 pp.
[cited by applicant]
Ganic et al., “PhUSE EU Connect 2018—Structure and Standardized Study Definition drives early study setup for added business benefits,” Bayer, Intilaris, Nov. 2018, 20 pp.
[cited by applicant]
Getz et al., “Measuring the Incidence, Causes, and Repercussions of Protocol Amendments,” Therapeutic Innovation and Regulatory Science, Drug Information Journal, vol. 45, Issue 3, May 2011, pp. 265-275.
[cited by applicant]
Seguine, “Overcoming the Industry's Data Crisis,” Clinical Link, EPC, Aug. 2019, pp. 38-41.
[cited by applicant]
“The Case for CDISC Standards,” CDISC, Business Case for CDISC Standards, Stage V, Sep. 30, 2014, 45 pp.
[cited by applicant]
“Information technology—Metadata registries (MDR)—Part 1: Framework,” International Standards, ISO/IEC 11179-1, Second Edition, Sep. 15, 2004, 32 pp.
[cited by applicant]
“Information technology—Metadata registries (MDR)—Part 2: Classification,” International Standards, ISO/IEC 11179-2, Second Edition, Nov. 15, 2005, 16 pp.
[cited by applicant]
“Information technology—Metadata registries (MDR)—Part 3: Registry metamodel and basic attributes,” International Standards, ISO/IEC 11179-3, Third Edition, Feb. 15, 2013, 244 pp.
[cited by applicant]
“Information technology—Metadata registries (MDR)—Part 4: Formulation of data definitions,” International Standards, ISO/IEC 11179-4, Second Edition, Jul. 15, 2004, 16 pp.
[cited by applicant]
“Information technology—Metadata registries (MDR)—Part 5: Naming principles,” International Standards, ISO/IEC 11179-5, Third Edition, Apr. 1, 2015, 32 pp.
[cited by applicant]
“Information technology—Metadata registries (MDR)—Part 6: Registration,” International Standards, ISO/IEC 11179-6, Third Edition, Aug. 1, 2015, 72 pp.
[cited by applicant]
Advisory Action from U.S. Appl. No. 17/305,366 dated Jan. 3, 2025, 2 pp.
[cited by applicant]
Response to Final Office Action dated Sep. 18, 2024 from U.S. Appl. No. 17/305,368 filed Dec. 17, 2024, 17 pp.
[cited by applicant]
Response to Final Office Action dated Sep. 28, 2024 from U.S. Appl. No. 17/305,366 filed Nov. 27, 2024, 18 pp.
[cited by applicant]
Jiang et al., “Using Semantic Web technologies for the generation of domain-specific templates to support clinical study metadata standards”, Journal of Biomedical Semantics, vol. 7, No. 10, BioMed Central, Mar. 6, 2016…
[cited by applicant]
Office Action from U.S. Appl. No. 17/305,366 dated Jan. 29, 2024, 32 pp.
[cited by applicant]
Response to Office Action dated Jan. 29, 2024 from U.S. Appl. No. 17/305,366 filed May 29, 2024, 21 pp.
[cited by applicant]
Response to Office Action dated Mar. 8, 2024 from U.S. Appl. No. 17/305,368 filed Jul. 8, 2024, 18 pp.
[cited by applicant]
Office Action from U.S. Appl. No. 17/305,366 dated Mar. 24, 2025, 28 pp.
[cited by applicant]
Final Office Action from U.S. Appl. No. 17/305,368 dated Apr. 22, 2025, 16 pp.
[cited by applicant]
Response to Office Action dated Jan. 6, 2025 from U.S. Appl. No. 17/305,368 filed Apr. 7, 2025, 16 pp.
[cited by applicant]